Skip to main content

Table 5 Average % CV of triplicate test of 10 individuals over 3 days

From: Validation of a flow cytometry based chemokine internalization assay for use in evaluating the pharmacodynamic response to a receptor antagonist

  CD14+MCP-1al+ CD4+MCP-1al+
  % MESF % N/A
Day 1 5.6 8.9 11.9 N/A
Day 2 2.2 8 13.9 N/A
Day 3 3 7.4 7.7 N/A
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us